Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind placebo-controlled trial of aerosolised liposomal ciclosporin A for bronchiolitis obliterans syndrome after allogeneic HSCT
2008-003801-15Phase 2Completed
- Sponsor
- PARI Pharma
- Start
- Jan 2009
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Bronchiolitis Obliterans Syndrome (BOS) and Bronchiolitis Obliterans (BO) comparing Aerosolised liposomal ciclosporin A with Placebo (sodium chloride solution) (2 arms). Started Jan 2009; status: completed.
02
Drugs
cyclosporine
03
Conditions
Bronchiolitis Obliterans Syndrome (BOS)Bronchiolitis Obliterans (BO)
Beyond the preview
Go deeper on 2008-003801-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-003801-15.